Overview of Dr. Green
Dr. Angela Green is an oncologist in West Harrison, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Tufts University School of Medicine and has been in practice 4 years. She is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She has more than 20 publications and over 400 citings.
Office
500 Westchester Avenue
West Harrison, NY 10604
Education & Training
University of North Carolina HospitalsResidency, Internal Medicine, 2013 - 2016
Tufts University School of MedicineClass of 2013
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2020 - 2025
NY State Medical License 2016 - 2025
NC State Medical License 2013 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer Start of enrollment: 2018 Aug 21
Roles: Contact, Principal Investigator
- Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer Start of enrollment: 2023 Dec 28
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer.Angela K Green, Qin Zhou, Alexia Iasonos, William A Zammarrelli, Britta Weigelt
Clinical Cancer Research. 2024-11-19 - Quality of Treatment Selection for Medicare Beneficiaries With Cancer.Aaron P Mitchell, Sonia Persaud, Akriti Mishra Meza, Hannah E Fuchs, Prabal De
Journal of Clinical Oncology. 2024-10-11 - 2 citationsAdverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer.William A Zammarrelli 3rd, Weining Ma, Kevin Espino, Sushmita Gordhandas, Effi Yeoshoua
Gynecologic Oncology. 2023-11-01
Press Mentions
Full Circle: MSK Patient Survives Deadly Cervical Cancer and Returns to Train as DoctorOctober 31st, 2024- Black Patients Still Underrepresented in Trials for New Drug ApprovalsMarch 11th, 2022
- Black Patients Still Underrepresented in Clinical TrialsMarch 11th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
